Elizabeth Goodwin

419 total citations
9 papers, 187 citations indexed

About

Elizabeth Goodwin is a scholar working on Molecular Biology, Cell Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Elizabeth Goodwin has authored 9 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Elizabeth Goodwin's work include Muscle Physiology and Disorders (4 papers), Toxoplasma gondii Research Studies (2 papers) and Muscle metabolism and nutrition (2 papers). Elizabeth Goodwin is often cited by papers focused on Muscle Physiology and Disorders (4 papers), Toxoplasma gondii Research Studies (2 papers) and Muscle metabolism and nutrition (2 papers). Elizabeth Goodwin collaborates with scholars based in United States, Sweden and India. Elizabeth Goodwin's co-authors include Júlio Casoy, Mark P. Connolly, Jacqueline Zummo, Ronald Kong, Joseph M. Colacino, Neil G. Almstead, Marla Weetall, Seongwoo Hwang, John Babiak and Jiyuan Ma and has published in prestigious journals such as Neurology, Drug Metabolism and Disposition and Frontiers in Oncology.

In The Last Decade

Elizabeth Goodwin

9 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Goodwin United States	7	114	72	64	26	18	9	187
Eloise M. Walker United Kingdom	7	43 0.4×	55 0.8×	56 0.9×	105 4.0×	5 0.3×	9	200
Pierre Cavaillès France	10	226 2.0×	132 1.8×	188 2.9×	26 1.0×	25 1.4×	16	428
Suzana Passos Chaves Brazil	12	49 0.4×	137 1.9×	46 0.7×	195 7.5×	7 0.4×	17	337
Jürgen Sievertsen Germany	9	35 0.3×	34 0.5×	20 0.3×	88 3.4×	7 0.4×	11	184
Bénédicte Hoareau‐Coudert France	8	24 0.2×	57 0.8×	53 0.8×	84 3.2×	4 0.2×	12	216
Divya C. Thomas India	8	29 0.3×	58 0.8×	27 0.4×	83 3.2×	3 0.2×	10	178
Tracy Saveria United States	9	37 0.3×	77 1.1×	106 1.7×	102 3.9×	10 0.6×	12	213
Sonja Ghidelli‐Disse United Kingdom	8	25 0.2×	31 0.4×	89 1.4×	112 4.3×	18 1.0×	13	210
Zhang‐Zhou Shen China	5	27 0.2×	140 1.9×	102 1.6×	16 0.6×	5 0.3×	9	199
Sanjay Shahi Australia	8	23 0.2×	139 1.9×	187 2.9×	103 4.0×	2 0.1×	20	334

Countries citing papers authored by Elizabeth Goodwin

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Goodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Goodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Goodwin more than expected).

Fields of papers citing papers by Elizabeth Goodwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Goodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Goodwin. The network helps show where Elizabeth Goodwin may publish in the future.

Co-authorship network of co-authors of Elizabeth Goodwin

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Goodwin. A scholar is included among the top collaborators of Elizabeth Goodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Goodwin. Elizabeth Goodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Branstrom, Arthur, Liangxian Cao, Bansri Furia, et al.. (2022). Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia. Frontiers in Oncology. 12. 832816–832816. 10 indexed citations

Stephens, Carolyn, et al.. (2022). Aromatic L-amino acid decarboxylase deficiency: a systematic review. Future Neurology. 17(4). 7 indexed citations

McDonald, Craig M., Francesco Muntoni, Mark Rance, et al.. (2021). Ataluren Delays Loss of Ambulation and Decline in Pulmonary Function in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (2553). Neurology. 96(15_supplement). 1 indexed citations

Shapiro, Geoffrey I., Edward O’Mara, Oscar L. Laskin, et al.. (2021). Pharmacokinetics and Safety of PTC596, a Novel Tubulin‐Binding Agent, in Subjects With Advanced Solid Tumors. Clinical Pharmacology in Drug Development. 10(8). 940–949. 14 indexed citations

Kong, Ronald, Jiyuan Ma, Seongwoo Hwang, et al.. (2020). Metabolism and Disposition of Ataluren after Oral Administration to Mice, Rats, Dogs, and Humans. Drug Metabolism and Disposition. 48(4). 317–325. 7 indexed citations

Kong, Ronald, Jiyuan Ma, Diksha Kaushik, et al.. (2020). Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacort. Pharmacology Research & Perspectives. 8(6). e00677–e00677. 2 indexed citations

Kong, Ronald, Jiyuan Ma, Seongwoo Hwang, et al.. (2020). In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren. Pharmacology Research & Perspectives. 8(2). e00576–e00576. 10 indexed citations

Goodwin, Elizabeth, et al.. (2017). Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review. Drugs in R&D. 17(4). 523–544. 116 indexed citations

Connolly, Mark P., et al.. (2017). Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis. Pathogens and Global Health. 111(1). 31–44. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact